Screener
Fulgent Genetics, Inc. FLGT Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| General and administrative | 27,684 | 25,291 |
| Amortization of intangible assets | 2,031 | 1,990 |
| Total operating expenses | 56,112 | 48,141 |
| Operating loss | (34,622) | (19,795) |
| Other income (expenses) | ||
| Interest income | 8,651 | 8,018 |
| Interest expense | (17) | (14) |
| Other income, net | 10 | 68 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s operating income?
- Fulgent Genetics, Inc. (FLGT) reported operating income of -$34.62M in Q1 2026.
- How has Fulgent Genetics, Inc.'s operating income changed year-over-year?
- Fulgent Genetics, Inc.'s operating income decreased by 74.9% year-over-year, from -$19.8M to -$34.62M.
- What is the long-term trend for Fulgent Genetics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s operating income has grown at a -39.4% compound annual growth rate (CAGR), from $675.95M to -$91.1M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Fulgent Genetics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude